167 related articles for article (PubMed ID: 14696561)
21. Changes in kidney function in patients with suppressed HIV RNA who substitute their protease inhibitor with atazanavir/ritonavir.
Hamzah L; Campbell L; Wandolo E; Engler B; Cheserem E; Naftalin C; Taylor C; Post FA
AIDS; 2015 Jan; 29(3):392-4. PubMed ID: 25686688
[No Abstract] [Full Text] [Related]
22. Reyataz dosing options discussed. Excerpts from the FDA atazanavir hearing.
Huff B
GMHC Treat Issues; 2003 Jun; 17(6):8-11. PubMed ID: 12913962
[No Abstract] [Full Text] [Related]
23. PI monotherapy effective as maintenance.
AIDS Patient Care STDS; 2005 Oct; 19(10):696. PubMed ID: 16232054
[No Abstract] [Full Text] [Related]
24. Anti-HIV agents. Atazanavir and raltegravir--an interesting combination.
TreatmentUpdate; 2009; 21(3):3-4. PubMed ID: 19623725
[No Abstract] [Full Text] [Related]
25. Anti-HIV agents. Atazanavir and saquinavir.
TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
[No Abstract] [Full Text] [Related]
26. A new protease inhibitor from Bristol-Myers Squibb.
TreatmentUpdate; 2001; 12(12):5. PubMed ID: 11570092
[No Abstract] [Full Text] [Related]
27. FDA notifications. Atazanavir capsule label is updated for pediatric patients.
AIDS Alert; 2008 May; 23(5):59-60. PubMed ID: 18637262
[No Abstract] [Full Text] [Related]
28. A king in the CASTLE? Optimum initial HIV protease inhibitor.
Torti C; Frank I
Lancet; 2008 Aug; 372(9639):604-6. PubMed ID: 18722849
[No Abstract] [Full Text] [Related]
29. Disappearance of renal stones in an HIV-1-infected patient after reduction of atazanavir dose.
Lanzafame M; Bonora S; Lattuada E; Calcagno A; Di Perri G; Concia E
AIDS Res Hum Retroviruses; 2014 Sep; 30(9):835-6. PubMed ID: 24998758
[No Abstract] [Full Text] [Related]
30. Atazanavir: a new protease inhibitor to treat HIV infection.
Musial BL; Chojnacki JK; Coleman CI
Am J Health Syst Pharm; 2004 Jul; 61(13):1365-74. PubMed ID: 15287232
[TBL] [Abstract][Full Text] [Related]
31. [New protease inhibitor against HIV. Viral load decreases--without lipid increase].
MMW Fortschr Med; 2003 Aug; 145(33-34):61. PubMed ID: 14526586
[No Abstract] [Full Text] [Related]
32. Anti-HIV agents. Kaletra + atazanavir.
TreatmentUpdate; 2005; 17(5):5. PubMed ID: 17219657
[No Abstract] [Full Text] [Related]
33. Report from the 2008 joint ICAAC/IDSA meeting. Darunavir and atazanavir: 96-week data from ARTEMIS and CASTLE.
Sax PE
AIDS Clin Care; 2008 Dec; 20(12):98. PubMed ID: 19271333
[No Abstract] [Full Text] [Related]
34. Urolithiasis in HIV-positive patients treated with atazanavir.
Couzigou C; Daudon M; Meynard JL; Borsa-Lebas F; Higueret D; Escaut L; Zucman D; Liotier JY; Quencez JL; Asselah K; May T; Neau D; Vittecoq D
Clin Infect Dis; 2007 Oct; 45(8):e105-8. PubMed ID: 17879904
[TBL] [Abstract][Full Text] [Related]
35. [Safety of atazanavir in patients with HIV and hepatitis B and/or C virus coinfection].
Rivero A; Camacho A; Pérez-Camacho I; Torre-Cisneros J
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():45-8. PubMed ID: 20116617
[TBL] [Abstract][Full Text] [Related]
36. Atazanavir affects saquinavir.
AIDS Patient Care STDS; 2005 Apr; 19(4):273-4. PubMed ID: 15918234
[No Abstract] [Full Text] [Related]
37. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
[No Abstract] [Full Text] [Related]
38. [Adverse effects of atazanavir].
Palacios R; González M; Ruiz J; Santos J
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():41-4. PubMed ID: 20116616
[TBL] [Abstract][Full Text] [Related]
39. Does atazanavir cause lipodystrophy?
Gazzard BG; Moyle G
J HIV Ther; 2004 May; 9(2):41-4. PubMed ID: 15238875
[TBL] [Abstract][Full Text] [Related]
40. Proton pump inhibitor therapy in atazanavir-treated patients: contraindicated?
Furtek KJ; Crum NF; Olson PE; Wallace MR
J Acquir Immune Defic Syndr; 2006 Mar; 41(3):394-6. PubMed ID: 16540945
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]